ARCHIVES

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

R. Lee Clark to Retire; Texas Starts Search for Successor

September 9, 1977

Intramural Clinical Research Could Lose “Critical Mass” – Chabner

November 11, 1994

Amgen, Genzyme, Thoratec Mourn Loss Of Executives Killed In Plane Hijackings.

September 21, 2001

Oncologist Urge FDA to Allow Cancer Patients Access to Silicone Implants, But Continue Study

March 6, 1992

DCE Board Oks Concept For Three Contracts In Radiation Epidemiology

June 29, 1984

FDA Expands Gleevec Indication For Children with Ph+ ALL

January 25, 2013